China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effectiveness and Safety of Crisugabalin Besylate for Migraine Prophylaxis: A RealWorld Observational Cohort Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133996
Registration Time: 2026/10/10
Type: Observational study
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346758
Published by HT Digital Content Services with permission from Health Daily Digest....